Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-14 10:50 am Purchase |
2025-03-31 | 13G | 10x Genomics, Inc. TXG |
ARK Investment Management LLC | 12,845,713 11.870% |
1,488,702 (+13.11%) |
Filing History |
| 2025-05-12 1:58 pm Sale |
2025-03-31 | 13G | 10x Genomics, Inc. TXG |
Nikko Asset Management Americas, Inc. | 5,362,656 5.000% |
-1,010,556 (-15.86%) |
Filing History |
| 2025-05-07 10:55 am Sale |
2025-04-30 | 13G | 10x Genomics, Inc. TXG |
FMR LLC | 5,647,993 5.200% |
-9,035,879 (-61.54%) |
Filing History |
| 2025-05-07 10:40 am Sale |
2025-03-31 | 13G | 10x Genomics, Inc. TXG |
FMR LLC | 14,683,872 13.000% |
-3,047,397 (-17.19%) |
Filing History |
| 2025-04-25 06:22 am Sale |
2025-03-31 | 13G | 10x Genomics, Inc. TXG |
Sumitomo Mitsui Trust Group Inc. | 5,363,366 5.000% |
-1,009,846 (-15.85%) |
Filing History |
| 2025-04-04 4:00 pm Purchase |
2025-04-01 | 13G | 10x Genomics, Inc. TXG |
Millennium Management LLC | 5,533,618 5.100% |
5,533,618 (New Position) |
Filing History |
| 2024-11-08 2:46 pm Purchase |
2024-09-30 | 13G | 10x Genomics, Inc. TXG |
Nikko Asset Management Americas, Inc. | 6,373,212 5.980% |
6,373,212 (New Position) |
Filing History |
| 2024-11-05 06:07 am Purchase |
2024-09-30 | 13G | 10x Genomics, Inc. TXG |
Sumitomo Mitsui Trust Group Inc. | 6,373,212 5.980% |
6,373,212 (New Position) |
Filing History |
| 2024-10-04 2:14 pm Purchase |
2024-09-30 | 13G | 10x Genomics, Inc. TXG |
The Vanguard Group | 10,972,930 10.300% |
1,961,598 (+21.77%) |
Filing History |
| 2024-08-12 11:16 am Purchase |
2024-07-31 | 13G | 10x Genomics, Inc. TXG |
ARK Investment Management LLC | 11,357,011 10.750% |
11,357,011 (New Position) |
Filing History |
| 2024-06-07 09:55 am Purchase |
2024-05-31 | 13G | 10x Genomics, Inc. TXG |
BAILLIE GIFFORD & CO | 2,777,115 2.630% |
2,777,115 (New Position) |
Filing History |
| 2024-02-13 4:55 pm Purchase |
2023-12-29 | 13G | 10x Genomics, Inc. TXG |
The Vanguard Group | 9,011,332 8.650% |
591,321 (+7.02%) |
Filing History |
| 2024-02-09 08:35 am Purchase |
2024-02-08 | 13G | 10x Genomics, Inc. TXG |
FMR LLC | 17,731,269 16.252% |
4,683,939 (+35.90%) |
Filing History |
| 2024-01-31 2:08 pm Purchase |
2023-12-31 | 13G | 10x Genomics, Inc. TXG |
BlackRock Inc. BLK |
5,705,051 5.500% |
385,872 (+7.25%) |
Filing History |
| 2024-01-29 11:43 am Sale |
2023-12-29 | 13G | 10x Genomics, Inc. TXG |
BAILLIE GIFFORD & CO | 7,919,976 7.600% |
-682,259 (-7.93%) |
Filing History |
| 2023-12-08 4:37 pm Sale |
2023-11-30 | 13G | 10x Genomics, Inc. TXG |
MORGAN STANLEY MS |
3,630,398 3.500% |
-1,509,063 (-29.36%) |
Filing History |
| 2023-07-10 4:38 pm Sale |
2023-06-30 | 13G | 10x Genomics, Inc. TXG |
MORGAN STANLEY MS |
5,139,461 5.200% |
-4,755,518 (-48.06%) |
Filing History |
| 2023-07-10 10:20 am Purchase |
2023-07-07 | 13G | 10x Genomics, Inc. TXG |
FMR LLC | 13,047,330 12.658% |
4,154,232 (+46.71%) |
Filing History |
| 2023-02-14 4:05 pm Unchanged |
2022-12-31 | 13G | 10x Genomics, Inc. TXG |
Venrock Associates VI L.P. | 4,828,247 4.900% |
0 (Unchanged) |
Filing History |
| 2023-02-09 10:54 am Purchase |
2022-12-30 | 13G | 10x Genomics, Inc. TXG |
The Vanguard Group | 8,420,011 8.810% |
865,969 (+11.46%) |
Filing History |